CR
Christopher J Rust
10% Owner
Christopher J Rust10% Owner
Christopher J Rust insider trades: OncoMed Pharmaceuticals (OMED) stock buys and sales
10% Owner, OncoMed Pharmaceuticals Last trade Jul 23, 2013 33 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
46
Open-market trades
since 2005
8
Companies
last trade 2013
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Christopher reports to the SEC
OMEDOncoMed Pharmaceuticals
10% Owner · last filing Jul 23, 2013
+$2.7M
GWREGuidewire Software
10% Owner · last filing Sep 25, 2012
-$91.9M
IMIIntermolecular
10% Owner · last filing Jun 15, 2012
-$3.7M
ATRCAtriCure
10% Owner · last filing Jun 14, 2012
-$3.6M
MXLMaxlinear
10% Owner · last filing Aug 22, 2012
-$8.2M
IMPVImperva
10% Owner · last filing Nov 15, 2011
+$2.8M
and 2 more companies
Open-market buys and sales
46 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jul 23, 2013 | OMED | ↑ Buy | 155,164 | $17.00 | $2.6M | Directly owned by USVP VIII | Jul 23, 2013 (0d) |
| Jul 23, 2013 | OMED | ↑ Buy | 1,498 | $17.00 | $25K | Directly owned by AFF VIII | Jul 23, 2013 (0d) |
| Jul 23, 2013 | OMED | ↑ Buy | 1,434 | $17.00 | $24K | Directly owned by EP VIII-A | Jul 23, 2013 (0d) |
| Jul 23, 2013 | OMED | ↑ Buy | 727 | $17.00 | $12K | Directly owned by EP VIII-B | Jul 23, 2013 (0d) |
| Sep 18, 2012 | GWRE | ↓ Sell | 16,395 | $31.27 | $513K | Directly owned by EP VIII-A | Sep 18, 2012 (0d) |
| Sep 18, 2012 | GWRE | ↓ Sell | 8,796 | $31.27 | $275K | Directly owned by EP VIII-B | Sep 18, 2012 (0d) |
| Jun 14, 2012 | IMI | ↓ Sell | 1,209 | $6.70 | $8K | Directly owned by USVP IX | Jun 15, 2012 (1d) |
| Jun 13, 2012 | IMI | ↓ Sell | 218,631 | $6.76 | $1.5M | Directly owned by USVP IX | Jun 13, 2012 (0d) |
| Jun 7, 2012 | ATRC | ↓ Sell | 3,279 | $9.44 | $31K | Directly Held by EP VIII-A | Jun 7, 2012 (0d) |
| Jun 7, 2012 | ATRC | ↓ Sell | 1,759 | $9.44 | $17K | Directly Held by EP VIII-B | Jun 7, 2012 (0d) |
| May 31, 2012 | IMI | ↓ Sell | 338,500 | $6.55 | $2.2M | Directly owned by USVP IX | May 31, 2012 (0d) |
| May 30, 2012 | MXL | ↓ Sell | 3,235 | $4.20 | $14K | Directly owned by EP VIII-A | May 31, 2012 (1d) |
| May 30, 2012 | MXL | ↓ Sell | 1,640 | $4.20 | $7K | Directly owned by EP VIII-B | May 31, 2012 (1d) |
| Apr 24, 2012 | GWRE | ↓ Sell | 3,155,311 | $28.25 | $89.1M | Directly owned by USVP VIII | Apr 25, 2012 (1d) |
| Apr 24, 2012 | GWRE | ↓ Sell | 29,561 | $28.25 | $835K | Directly owned by EP VIII-A | Apr 25, 2012 (1d) |
| Apr 24, 2012 | GWRE | ↓ Sell | 23,250 | $28.25 | $657K | Directly owned by AFF VIII | Apr 25, 2012 (1d) |
| Apr 24, 2012 | GWRE | ↓ Sell | 15,860 | $28.25 | $448K | Directly owned by EP VIII-B | Apr 25, 2012 (1d) |
| Nov 9, 2011 | IMPV | ↑ Buy | 150,823 | $18.00 | $2.7M | Directly owned by USVP VIII | Nov 9, 2011 (0d) |
| Nov 9, 2011 | IMPV | ↑ Buy | 1,392 | $18.00 | $25K | Directly owned by EP VIII-A | Nov 9, 2011 (0d) |
| Nov 9, 2011 | IMPV | ↑ Buy | 704 | $18.00 | $13K | Directly owned by EP VIII-B | Nov 9, 2011 (0d) |
| May 27, 2011 | MXL | ↓ Sell | 4,621 | $8.95 | $41K | Directly owned by EP VIII-A | May 31, 2011 (4d) |
| May 27, 2011 | MXL | ↓ Sell | 2,342 | $8.95 | $21K | Directly owned by EP VIII-B | May 31, 2011 (4d) |
| May 26, 2011 | MXL | ↓ Sell | 2,994 | $8.93 | $27K | Directly owned by EP VIII-A | May 26, 2011 (0d) |
| May 26, 2011 | MXL | ↓ Sell | 1,518 | $8.93 | $14K | Directly owned by EP VIII-B | May 26, 2011 (0d) |
| Feb 15, 2011 | MXL | ↓ Sell | 2,552 | $11.54 | $29K | Directly owned by EP VIII-A | Feb 16, 2011 (1d) |
| Feb 15, 2011 | MXL | ↓ Sell | 1,294 | $11.54 | $15K | Directly owned by EP VIII-B | Feb 16, 2011 (1d) |
| Nov 29, 2010 | MXL | ↓ Sell | 2,937 | $10.54 | $31K | Directly owned by EP VIII-A | Nov 30, 2010 (1d) |
| Nov 29, 2010 | MXL | ↓ Sell | 1,478 | $10.54 | $16K | Directly owned by EP VIII-B | Nov 30, 2010 (1d) |
| Nov 15, 2010 | MXL | ↓ Sell | 1,473 | $10.52 | $15K | Directly owned by EP VIII-A | Nov 17, 2010 (2d) |
| Nov 15, 2010 | MXL | ↓ Sell | 747 | $10.52 | $8K | Directly owned by EP VIII-B | Nov 17, 2010 (2d) |
| Mar 29, 2010 | MXL | ↓ Sell | 555,107 | $14.00 | $7.8M | Directly owned by USVP VIII | Mar 29, 2010 (0d) |
| Mar 29, 2010 | MXL | ↓ Sell | 5,358 | $14.00 | $75K | Directly owned by AFF VIII | Mar 29, 2010 (0d) |
| Mar 29, 2010 | MXL | ↓ Sell | 5,130 | $14.00 | $72K | Directly owned by EP VIII-A | Mar 29, 2010 (0d) |
| Mar 29, 2010 | MXL | ↓ Sell | 2,600 | $14.00 | $36K | Directly owned by EP VIII-B | Mar 29, 2010 (0d) |
| Sep 14, 2009 | ALTU | ↓ Sell | 293,611 | $0.32 | $95K | Directly Owned by USVP VIII | Sep 16, 2009 (2d) |
| Sep 14, 2009 | ALTU | ↓ Sell | 2,756 | $0.32 | $894 | Directly Owned by EP VIII-A | Sep 16, 2009 (2d) |
| Sep 14, 2009 | ALTU | ↓ Sell | 2,161 | $0.32 | $701 | Directly Owned by AFF VIII | Sep 16, 2009 (2d) |
| Sep 14, 2009 | ALTU | ↓ Sell | 1,472 | $0.32 | $477 | Directly Owned by EP VIII-B | Sep 16, 2009 (2d) |
| Aug 10, 2006 | ATRC | ↓ Sell | 84,480 | $5.80 | $490K | Directly Held by USVP VIII | Aug 11, 2006 (1d) |
| Aug 10, 2006 | ATRC | ↓ Sell | 791 | $5.80 | $5K | Directly Held by EP VIII-A | Aug 11, 2006 (1d) |
| Aug 10, 2006 | ATRC | ↓ Sell | 622 | $5.80 | $4K | Directly Held by AFF VIII | Aug 11, 2006 (1d) |
| Aug 10, 2006 | ATRC | ↓ Sell | 424 | $5.80 | $2K | Directly Held by EP VIII-B | Aug 11, 2006 (1d) |
| Aug 10, 2005 | ATRC | ↓ Sell | 268,738 | $11.16 | $3.0M | Directly Held by USVP VIII | Aug 10, 2005 (0d) |
| Aug 10, 2005 | ATRC | ↓ Sell | 1,498 | $11.16 | $17K | Directly Held by EP VIII-A | Aug 10, 2005 (0d) |
| Aug 10, 2005 | ATRC | ↓ Sell | 1,178 | $11.16 | $13K | Directly Held by AFF VIII | Aug 10, 2005 (0d) |
| Aug 10, 2005 | ATRC | ↓ Sell | 804 | $11.16 | $9K | Directly Held by EP VIII-B | Aug 10, 2005 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Christopher J Rust's insider trades
Christopher J Rust is a 10% owner of OncoMed Pharmaceuticals (OMED). Since Aug 10, 2005, Christopher has reported 7 open-market purchases worth $5.5M and 39 sales worth $107.4M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include other transactions (14 filings), conversions (12 filings), option exercises (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every OMED insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.